Regen BioPharma Inc (OTC:RGBP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported Q0 revenue of .
Regen BioPharma Inc's stock currently trades at $0.00 with a market capitalization of $189.3K.